Search results
Showing 16 to 30 of 181 results for nice conference
NICE decision aid: process guide
Evidence-based recommendations on transperineal biopsy for diagnosing prostate cancer
Macimorelin for diagnosing growth hormone deficiency (MIB320)
NICE has developed a medtech innovation briefing (MIB) on macimorelin for diagnosing growth hormone deficiency .
Early value assessment is a new evidence-based approach designed to improve the care of people and effective use of NHS resources through quicker access to promising health technologies that address national unmet need. It champions stronger partnership working between regulatory, healthcare and research organisations to benefit people and better support innovators while ensuring value for money for the NHS
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis (IPG746)
Evidence-based recommendations on tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. This involves inserting a catheter under the skin in the abdomen to drain excess fluid when needed, at home or in community care. The aim is to reduce the need for hospital admissions and improve quality of life.
View recommendations for IPG746Show all sections
NICE has developed a medtech innovation briefing (MIB) on digital technologies for the detection of melanoma .
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer (MTG72)
Evidence-based recommendations on Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer.
View recommendations for MTG72Show all sections
NICE has developed a medtech innovation briefing (MIB) on TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart failure .
This guideline covers the planning, delivery and review of social work interventions for adults who have complex needs. It promotes ways for social work professionals, other care staff and people with complex needs to work together to make decisions about care and support.
Evidence-based recommendations on niraparib (Zejula) for treating relapsed, platinum-sensitive high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer in adults.
UroShield for preventing catheter-associated urinary tract infections (MTG69)
Evidence-based recommendations on UroShield for preventing catheter-associated urinary tract infections.
View recommendations for MTG69Show all sections
to other NICE resources including Patient experience in adult NHS services overview , Patient Experience in Adult NHS Services CG138 ,...
icobrain ms for active relapsing–remitting multiple sclerosis (MIB291)
NICE has developed a medtech innovation briefing (MIB) on icobrain ms for active relapsing–remitting multiple sclerosis .
A quick guide to recognising and responding to domestic violence and abuse
reflecting the NICE principles of 'patient centred care' and 'personalised package of care and information' (Recommendation 1.4,...